E-LIB Suche - Ergebnisse für: Bangma, Amber

1

Mucosal host-microbe interactions associate with clinical p..:

Hu, Shixian ; Bourgonje, Arno R. ; Gacesa, Ranko...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

34 SINGLE-CELL RNA SEQUENCING IN PATIENTS WITH PRIMARY SCLE..:

Bangma, Amber ; Pibiri, Paola ; Sun, Shiqiang...
Gastroenterology. 166 (2024) 5 - p. S-13 , 2024

Link: https://doi.org/10.1016/..

3

Mo1796 MUCOSAL HOST-MICROBE INTERACTIONS ASSOCIATE WITH CLI..:

Bourgonje, Arno R. ; Hu, Shixian ; Gacesa, Ranko...
Gastroenterology. 164 (2023) 6 - p. S-914-S-915 , 2023

Link: https://doi.org/10.1016/..

4

Polygenetic risk scores do not add predictive power to clin..:

Karmi, Naomi ; Bangma, Amber ; Spekhorst, Lieke M....
PLOS ONE. 16 (2021) 9 - p. e0256860 , 2021

Link: https://doi.org/10.1371/..

5

TNFα-Antagonist Use and Mucosal Inflammation Are Associated..:

Bangma, Amber ; Voskuil, Michiel D. ; Weersma, Rinse K.
Gastroenterology. 160 (2021) 7 - p. 2621-2622 , 2021

Link: https://doi.org/10.1053/..

6

Predicted efficacy of a pharmacogenetic passport for inflam..:

Bangma, Amber ; Voskuil, Michiel D. ; Uniken Venema, Werna T. C....
Alimentary Pharmacology & Therapeutics. 51 (2020) 11 - p. 1105-1115 , 2020

Link: https://doi.org/10.1111/..

7

Mucosal microbiota modulate host intestinal immune signatur..:

Hu, Shixian ; Bourgonje, Arno R ; Gacesa, Ranko...
https://research.rug.nl/en/publications/6b3f3ec0-3ee8-4722-a63a-f3d91153e542. , 2022

Link: https://hdl.handle.net/1..

8

TNFα-antagonist use and mucosal inflammation are associated..:

Bangma, Amber ; Voskuil, Michiel Dirk ; Weersma, Rinse K
https://research.rug.nl/en/publications/b784c8ae-0421-43b2-976b-1b705ac3759d. , 2021

Link: https://hdl.handle.net/1..

9

Polygenetic risk scores do not add predictive power to clin..:

Karmi, Naomi ; Bangma, Amber ; Spekhorst, Lieke M...
https://research.rug.nl/en/publications/f1ae2574-a037-448c-8234-33ee9354b703. , 2021

Link: https://hdl.handle.net/1..

10

Predicted efficacy of a pharmacogenetic passport for inflam..:

Bangma, Amber ; Voskuil, Michiel D ; Uniken Venema, Werna T. C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318341/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Predicted efficacy of a pharmacogenetic passport for inflam..:

Bangma, Amber ; Voskuil, Michiel D ; Uniken Venema, Werna T C...
https://research.rug.nl/en/publications/c8f0c420-782d-435d-895f-3decda858b3c. , 2020

Link: https://hdl.handle.net/1..

12

Predicting (side) effects for patients with inflammatory bo..:

Voskuil, Michiel Dirk ; Bangma, Amber ; Weersma, Rinse Karel.
https://research.rug.nl/en/publications/0248f205-a9d2-4d8a-bac5-fb094888ff0b. , 2019

Link: https://hdl.handle.net/1..

13

Polygenetic risk scores do not add predictive power to clin..:

Naomi Karmi ; Amber Bangma ; Lieke M Spekhorst...
https://doi.org/10.1371/journal.pone.0256860. , 2021

Link: https://doi.org/10.1371/..

14

Case and control criteria:

Naomi Karmi (11450110) ; Amber Bangma (11450113) ; Lieke M. Spekhorst (3142986)...
https://figshare.com/articles/journal_contribution/Case_and_control_criteria_/16636324. , 2021

Link: https://doi.org/10.1371/..

15

Comparison of characteristics of patients with Crohn's dise..:

Naomi Karmi (11450110) ; Amber Bangma (11450113) ; Lieke M. Spekhorst (3142986)...
https://figshare.com/articles/dataset/Comparison_of_characteristics_of_patients_with_Crohn_s_disease_exposed_to_anti-tumour_necrosis_factor_alpha_therapy_with_durable_response_and_loss_of_response_/16636351. , 2021

Link: https://doi.org/10.1371/..